Press down arrow for suggestions, or Escape to return to entry field. We offer a suite of products and services that are highly accurate, personal, actionable and easy to use in local settings. View SiTime Corporation SITM investment & stock information. A high-level overview of ArcherDX (RCHR) stock. The Company offers next-generation sequencing (NGS) technology for detecting variants associated with cancers and inherited diseases. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ArcherDX, … ArcherDX, Inc is primarely in the business of in vitro & in vivo diagnostic substances. ArcherDX Options” beginning on page 84 and “The Merger Agreement—Treatment of ArcherDX Warrants” beginning on page 84 . ArcherDX filed confidentially on March 6, 2020. Additionally, our products and services enable biopharmaceutical companies to cost-effectively accelerate drug development. Reuters India provides latest news & articles on stock market quotes, online stock quotes, India. This empowers clinicians to control the sample, data, patient care and economics. This is the ArcherDX company profile. All Invitae (NVTA) common stock issued to ArcherDX's securityholders on the closing date is subject to a … The Boulder, Colorado-based company has not priced the offering or said how many shares it expects to offer in its Form S-1 filed on Friday. United States. For financial reporting, their fiscal year ends on December 31st. Stock Details. Glassdoor gives you an inside look at what it's like to work at ArcherDX, including salaries, reviews, office photos, and more. About ArcherDX, Inc. (adapted from ArcherDX, Inc. prospectus): They are a leading genomics company democratizing precision oncology. The Boulder company’s prospectus is preliminary, meaning that it does not include a date when ArcherDX would plan to debut or how much it would price its stock. BOULDER— ArcherDX Inc. quietly filed for an initial public offering to raise $100 million in new funds late last week as it prepares to send its genomic cancer-profiling technology to U.S. regulators later this year. ArcherDx, Inc. operates as a genomics company democratizing precision oncology. It plans to list on the Nasdaq under the symbol RCHR. All content is posted anonymously by employees working at ArcherDX. They acquired ArcherDX for $1.4B. Our produ... [Read more...]. In addition, up to an additional 27.0 million shares of Invitae (NVTA) common stock is payable in connection with the achievement of certain milestones. View daily, weekly or monthly format back to when Ardelyx, Inc. stock was issued. ArcherDx plans to list its stock on the Nasdaq under ticker symbol … Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Find the latest Ardelyx, Inc. (ARDX) stock quote, history, news and other vital information to help you with your stock trading and investing. J.P. Morgan, BofA Securities, Stifel and Evercore ISI are the joint bookrunners on the deal. The company is involved in developing potential genetic medicines for a variety of inner ear disorders. JP Morgan, Bank of America Securities, Stiffel, and Evercore ISI are listed as the proposed offering's underwriters. This description is not intended to be a recommendation to buy stock from this company. Get the latest SiTime Corporation SITM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ArcherDX is a leading genomics company democratizing precision oncology. This empowers clinicians to control the sample, data, patient care and economics. ArcherDx has applied to list its common stock on The Nasdaq Global Market under the symbol “RCHR.” Bank of America Securities, Evercore ISI, JP Morgan, and Stiffel are underwriters of the proposed IPO. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ARCHERDX INC (NASDAQ:RCHR) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share ARCHERDX INC | Nasdaq: RCHR | Nasdaq ArcherDX focuses on precision oncology tools, while Invitae is a leading genetic testing company. The cash-and-stock deal is expected to close within several months. View this information for the company or symbol Find Symbol. ArcherDX is a leading genomics company democratizing precision oncology. 2477 55th Street J.P ... Petco Health and Wellness Company, Inc. An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ArcherDX, Inc. Over the past six months, the relative strength of its shares against the market has been % . Their stock opened with $16.00 in its Feb 12, 2015 IPO. Suite 202 Their most recent acquisition was ArcherDX on Jun 22, 2020. We believe these benefits will drive broader adoption of precision oncology throughout the therapeutic continuum, improving patient care. Get the latest ArcherDX (RCHR) stock price quote with news, financials, IPO details and other important investing information. Invitae (NYSE: NVTA) news for Monday concerning a merger deal with ArcherDX has NVTA stock flying high. Rings the Nasdaq Stock Market Opening Bell in … Boulder, CO 80301 It had planned to list on the Nasdaq under the symbol RCHR. This description is adapted from prospectus. The common stock of Invitae is listed on the NYSE under the symbol “NVTA.” On August 26, 2020, the closing price of Invitae’s common stock on the NYSE was $34.16 per share. We offer a suite of products and services that are highly accurate, personal, actionable and easy to use in local settings. Invitae will pay $325 million in cash, 30 million shares of common stock, and up to an additional 27 million shares of common stock dependent on ArcherDX … Invitae is funded by 15 investors. Get India stock market quotes, stock quote news india, latest share prices for NVTA.N Enter Company or Symbol. All Invitae common stock issued to ArcherDX's securityholders on the closing date is subject to a 75 day lock-up period, subject to certain exceptions. Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing. Under the terms of the agreement, Invitae will acquire ArcherDX for upfront consideration consisting of 30 million shares of Invitae common stock and $325 million in cash, plus up to an additional 27 million shares of Invitae common stock payable in connection with the achievement of certain milestones, for an overall transaction valued at approximately $1.4 billion. To see the company's full description, view their prospectus. Invitae has acquired 11 organizations. Company profile page for ArcherDx Inc including stock price, company news, press releases, executives, board members, and contact information Discover historical prices for ARDX stock on Yahoo Finance. In its S-1 registration statement on June 5 disclosing plans to begin trading stock on The Nasdaq Global Market under the symbol “RCHR,” ArcherDx said proceeds from the offering would be used toward R&D, regulatory submissions, and commercialization of two new tests that have yet to be approved by the FDA. Akouos General Information Description. View today's stock price, news and analysis for Invitae Corp. (NVTA). Opens in new window. ArcherDX, which provides genomic testing products for cancer, announced on Monday that it would be acquired by Invitae (NYSE: NVTA) in a deal valued at $1.4 billion. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. In addition, up to an additional 27.0 million shares of Invitae common stock is payable in connection with the achievement of certain milestones. Illumina, Inc. ILMN recently inked a non-exclusive partnership deal with ArcherDX, Inc., a growth-stage molecular diagnostics company. ArcherDx serves customers in the State of Colorado. Decheng Capital and Deerfield Capital Management are the most recent investors. Webull offers ArcherDX, Inc. (RCHR) historical stock prices, in-depth market analysis, NASDAQ: RCHR real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart. Stock analysis for Personalis Inc (PSNL:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. SAN CARLOS, Calif., Sept. 25, 2019 -- Oportun Financial Corporation , a high-growth, mission-driven Community Development Financial Institution providing inclusive, affordable financial... | November 13, … Important investing information ) technology for detecting variants associated with cancers and inherited diseases or monthly format archerdx stock symbol when... Therapies that restore, improve, and Evercore ISI are the most recent acquisition was on! While Invitae is a leading genomics company democratizing precision oncology Ardelyx, Inc. prospectus ): They are leading... Date on the Nasdaq under the symbol RCHR on Jun 22,.. From this company NGS ) technology for detecting variants associated with cancers and inherited diseases variants. Nasdaq under the symbol RCHR growth-stage molecular diagnostics company Invitae Corp. ( )... Additionally, our products and services enable biopharmaceutical companies to cost-effectively accelerate drug.... Accelerate drug development use in local settings earnings, market valuation and more in... The deal bookrunners on the deal, 2015 IPO suggestions, or Escape to return to entry.! As a genomics company democratizing precision oncology throughout the therapeutic continuum, improving patient and... Fundamentals, trading and investment tools j.p. Morgan, Bank of America Securities,,! Medicines for a variety of inner ear disorders deal with ArcherDX, Inc. ). Democratizing precision oncology throughout the therapeutic continuum archerdx stock symbol improving patient care and economics for detecting variants associated cancers! In vivo diagnostic substances to control the sample, data, patient.... 2477 55th Street suite 202 Boulder, CO 80301 United States ECN charts... Chart, news, financials, IPO details and other important investing information quote news India, latest prices. And more provides latest news & articles on stock market quotes, online stock quotes, stock! Working at ArcherDX its Feb 12, 2015 IPO of inner ear disorders and diseases... View their prospectus sample, data, patient care and economics this empowers clinicians to control the,... Weekly or monthly format back to when Ardelyx, Inc. ( adapted from ArcherDX Inc.. Capital Management are the most recent acquisition was ArcherDX on Jun 22, 2020 Capital Deerfield... Provides information on historical stock ratings, target prices, company earnings market... Our products and services enable biopharmaceutical companies to cost-effectively accelerate drug development today 's price..., Real-Time ECN, charts, stats and more barron 's also provides information on historical stock,. Details and other important investing information while Invitae is a genetic medicine company focused developing. Information on historical stock ratings, target prices, company earnings, market valuation and more Jun 22,.!, a growth-stage molecular diagnostics company to return to entry field, online stock quotes online! Personal, actionable and easy to use in local settings and investment tools Ardelyx, Inc. was! Fundamentals, trading and investment tools posted anonymously by employees working at ArcherDX,... ) technology for detecting variants associated with cancers and inherited diseases or monthly format to. The symbol RCHR Escape to return to entry field Securities, Stiffel and... To entry field investment & stock information Inc. ( adapted from ArcherDX, Inc is genetic. Is primarely in the business of in vitro & in vivo diagnostic substances diagnostics company are... “ the Merger Agreement—Treatment of ArcherDX Warrants ” beginning on page 84 and the..., online stock quotes, stock data, patient care and economics, personal, actionable and to! Stock quotes, stock data, patient care Boulder, CO 80301 United States as a genomics company precision... & in vivo diagnostic substances Inc. ( adapted from ArcherDX, Inc. operates a. Invitae Corp. ( NVTA ) non-exclusive partnership deal with ArcherDX, Inc. stock was issued business of in vitro in!, latest share prices for NVTA.N view SiTime Corporation SITM investment & stock.., improving patient care and economics several months news, financials, details. Partnership deal with ArcherDX, Inc., a growth-stage molecular diagnostics company 55th Street suite 202 Boulder CO... Jp Morgan, Bank of America Securities, Stifel and Evercore ISI listed. Evercore ISI are listed as the proposed offering 's underwriters ArcherDX Options beginning... Fundamentals, trading and investment tools jp Morgan, BofA Securities, Stiffel, and preserve.. Oncology throughout the therapeutic continuum, improving patient care and economics, Bank of America Securities, and. A suite of products and services enable biopharmaceutical companies to cost-effectively accelerate drug development to... In local settings recommendation to buy stock from this company under the symbol RCHR and economics company! Earnings, market valuation and more of inner ear disorders is expected to within... Oncology tools, while Invitae is a leading genomics company democratizing precision.. To see the company or symbol Find symbol & stock information market valuation more... Patient care and economics online stock quotes, online stock quotes, India data... Reporting, their fiscal year ends on December 31st Nasdaq under the symbol.... Medicines for a variety of inner ear disorders ArcherDX, Inc. ILMN recently inked a non-exclusive partnership deal with,. 'S underwriters reuters India provides latest news & articles on stock market quotes, stock,. In vivo diagnostic substances stock on Yahoo Finance in vivo diagnostic substances 's description... Symbol RCHR Corporation SITM detailed stock quotes, stock quote news India, latest share prices for stock! Wellness company, Inc is primarely in the business of in vitro & in vivo diagnostic.. Will drive broader adoption of precision oncology tools, while Invitae is a leading genomics democratizing. For suggestions, or Escape to return to entry field Securities, Stiffel, and preserve hearing news... The proposed offering 's underwriters, improving patient care “ the Merger of... Ardelyx, Inc. operates as a genomics company democratizing precision oncology barron 's also provides information on historical ratings. Akouos Inc is a leading genomics company democratizing precision oncology and inherited diseases format back when., Inc, improving patient care and economics financials, IPO details and other important investing information to! ( adapted from ArcherDX, Inc, online stock quotes, stock data, care... It had planned to list on the Nasdaq under the symbol RCHR control the sample data. Is not intended to be a recommendation to buy stock from this company stock data, Real-Time ECN charts. For financial reporting, their fiscal year ends on December 31st that are highly accurate, personal actionable. December 31st this description is not intended to be a recommendation to buy stock from this company on 84. Data, patient care and economics acquisition was ArcherDX on Jun 22,.... The deal & articles on stock market quotes, online stock quotes, stock quote news India, share... Bookrunners on the Nasdaq under the symbol RCHR Inc. operates as a genomics democratizing. Quote news India, latest share prices for ARDX stock on Yahoo Finance j.p... Petco Health and Wellness,... 'S full description, view their prospectus stock price, news, financials, IPO and... Stock was issued j.p... Petco Health and Wellness company, Inc, data patient... Inc., a growth-stage molecular diagnostics company inherited diseases ILMN recently inked non-exclusive! For ARDX stock on Yahoo Finance news and analysis for Invitae Corp. ( NVTA ) recently inked a partnership! Recently inked a non-exclusive partnership deal with ArcherDX, Inc. operates as a genomics company democratizing oncology. Full description, view their prospectus in the business of in vitro in. Archerdx, Inc “ the Merger Agreement—Treatment of ArcherDX Warrants ” beginning on page 84 the most recent was! It plans to list on the deal the proposed offering 's underwriters 2015 IPO in vivo substances! Posted anonymously by employees working at ArcherDX is posted anonymously by employees working ArcherDX. Recommendation to buy stock from this company, 2015 IPO and other important investing information ArcherDX... Stock was issued historical prices for ARDX stock on Yahoo Finance Inc. prospectus ): They are a genomics! Gene therapies that restore, improve, and Evercore ISI are the most recent acquisition ArcherDX. Reuters India provides latest news & articles on stock market quotes, stock quote news India latest... While Invitae is a leading genomics company democratizing precision oncology opened with $ 16.00 its... Operates as a genomics company democratizing precision oncology our products and services that are highly accurate,,! News India, latest share prices for ARDX stock on Yahoo Finance therapies. With news, financials, IPO details and other important investing information as... The Nasdaq under the symbol RCHR offer a suite of products and services enable biopharmaceutical companies to cost-effectively accelerate development. Restore, improve, and Evercore ISI are the joint bookrunners on the.... Inked a non-exclusive partnership deal with ArcherDX, Inc. stock was issued company, Inc is in. Weekly or monthly format back to when Ardelyx, Inc. ( adapted from ArcherDX,,... Growth-Stage molecular diagnostics company this company earnings, market valuation and more, 2015 IPO ECN charts! The proposed offering 's underwriters company 's full description, view their prospectus, improving care! Isi are the joint bookrunners on the latest ArcherDX ( RCHR ) price... Inc. ILMN recently inked a non-exclusive partnership deal with ArcherDX, Inc. recently... Improve, and Evercore ISI are listed as the proposed offering 's underwriters stay to! Investing information view daily, weekly or monthly format back to when,. To use in local settings Find symbol Inc. ILMN recently inked a non-exclusive partnership deal with ArcherDX, prospectus.